OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia

Positive

AI Analysis

Summary

OrbiMed raised two new life sciences funds totaling $3B. One of them, the sixth cycle of its Asia Partners fund, includes more than $1B earmarked for life science companies based in Asia.

Outcome Details

OrbiMed raised two new life sciences funds totaling $3B, including a sixth-cycle Asia Partners fund with more than $1B earmarked for Asia-based life science companies.

Importance:5/10

Sentiment:

0.50

venture capitalfundraisinglife sciences fundingAsiaOrbiMedinvestment funds

Read the original article

Published by BioSpace on October 16, 2026 11:50 AM

Read Original